Systematic Review: How Pharma Marketing Influences Doctor Prescribing Habits

Gifts, payments, and promotional activities from pharmaceutical companies directly influence doctors to increase prescription numbers and alter prescribing appropriateness, according to a systematic review current to January 2025.

How Industry Marketing Shapes Prescribing Habits

Pharmaceutical companies interact with healthcare professionals through a wide range of promotional strategies designed to increase sales. These interactions include sales representative visits, direct mail, medical journal advertisements, conference event sponsorships, and gifts such as food, travel expenses, free drug samples, and advisory board payments. According to the review, pharmaceutical companies spent nearly 30,000 million US dollars on marketing and promotion in the United States in 2016 alone.

To determine the real-world impact of these promotional practices, researchers analyzed 93 studies examining four specific measures: prescribing appropriateness, prescription quantity, prescription costs, and hospital formulary requests. Of these studies, 82 took place in the United States, while the remaining 11 occurred in the United Kingdom and Europe.

The Direct Impact of Gifts, Payments, and Advertising

The review evaluated advertising and education primarily through sales representative visits across 16 studies. Compared to no or less exposure, pharmaceutical advertising and education aimed at doctors may increase inappropriate prescribing, based on data from 6 studies involving 1,335 doctors. This promotional activity probably increases the quantity of prescriptions, backed by 7 studies of 151,399 doctors, and may increase prescription costs based on 2 studies of 986 doctors. Evidence regarding hospital formulary requests remained very uncertain.

Gifts and payments from the pharmaceutical industry showed even more pronounced effects across 62 studies. Financial contributions and gifts increase inappropriate prescribing, as demonstrated across 10 studies involving 2.9 million doctors. These perks also increase prescription volume, supported by 39 studies covering 3.8 million doctors, and probably increase prescription costs across 25 studies involving 2.5 million doctors. In contrast, researchers found extreme uncertainty regarding whether free medicine samples affect prescribing habits, appropriateness, or costs.

The Regulatory Effect of Conflict-of-Interest Policies

Implementing strict institutional rules changes how clinicians respond to industry influence. Conflict-of-interest policies that restrict or manage interactions between pharmaceutical companies and doctors probably improve prescribing appropriateness, according to 2 studies involving 3,065 doctors. These regulatory policies may decrease prescribing quantity, based on 6 studies covering 110,470 doctors. Their direct effect on prescription costs remains uncertain, and none of the examined studies measured changes to formulary requests.

While the reviewed studies demonstrate a clear and consistent pattern where increased interaction correlates with less appropriate prescribing and higher volume, the observational methods prevent researchers from declaring definitive causation. Because all included studies occurred in the United States, the United Kingdom, and Europe, the extent to which these marketing dynamics affect prescribing behavior in other global regions remains unmeasured.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.